Literature DB >> 15821101

Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling.

I K Lund1, J A Hansen, H S Andersen, N P H Møller, N Billestrup.   

Abstract

Upon leptin binding, the leptin receptor is activated, leading to stimulation of the JAK/STAT signal transduction cascade. The transient character of the tyrosine phosphorylation of JAK2 and STAT3 suggests the involvement of protein tyrosine phosphatases (PTPs) as negative regulators of this signalling pathway. Specifically, recent evidence has suggested that PTP1B might be a key regulator of leptin signalling, based on the resistance to diet-induced obesity and increased leptin signalling observed in PTP1B-deficient mice. The present study was undertaken to investigate the mechanism by which PTP1B mediates the cessation of the leptin signal transduction. Leptin-induced activation of a STAT3 responsive reporter was dose-dependently inhibited by co-transfection with PTP1B. No inhibition was observed when a catalytically inactive mutant of PTP1B was used or when other PTPs were co-transfected. PTP1B was able to dephosphorylate activated JAK2 and STAT3 in vitro, whereas either no or a minimal effect was observed with cluster of differentiation 45 (CD45), PTPalpha and leukocyte antigen-related (LAR). By utilisation of a selective PTP1B inhibitor, the leptin-induced STAT3 activation was enhanced in cells. In conclusion, these results suggested that the negative regulatory role of PTP1B on leptin signalling is mediated through a direct and selective dephosphorylation of the two signalling molecules, JAK2 and STAT3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821101     DOI: 10.1677/jme.1.01694

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  30 in total

1.  A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma.

Authors:  Natsuko Suwaki; Elsa Vanhecke; Katelyn M Atkins; Manuela Graf; Katherine Swabey; Paul Huang; Peter Schraml; Holger Moch; Amy Mulick Cassidy; Daniel Brewer; Bissan Al-Lazikani; Paul Workman; Johann De-Bono; Stan B Kaye; James Larkin; Martin E Gore; Charles L Sawyers; Peter Nelson; Tomasz M Beer; Hao Geng; Lina Gao; David Z Qian; Joshi J Alumkal; Gary Thomas; George V Thomas
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

Review 2.  Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Authors:  Graziela Z Kalil; William G Haynes
Journal:  Hypertens Res       Date:  2011-11-03       Impact factor: 3.872

3.  Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues.

Authors:  Bingzhong Xue; Thomas Pulinilkunnil; Incoronata Murano; Kendra K Bence; Huamei He; Yasuhiko Minokoshi; Kenji Asakura; Anna Lee; Fawaz Haj; Noboru Furukawa; Karyn J Catalano; Mirela Delibegovic; James A Balschi; Saverio Cinti; Benjamin G Neel; Barbara B Kahn
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

4.  Selenate enhances STAT3 transcriptional activity in endothelial cells: differential actions of selenate and selenite on LIF cytokine signaling and cell viability.

Authors:  Hani J Alturkmani; Carlos Zgheib; Fouad A Zouein; Nour Eddin F Alshaaer; Mazen Kurdi; George W Booz
Journal:  J Inorg Biochem       Date:  2012-01-28       Impact factor: 4.155

Review 5.  Central leptin receptor action and resistance in obesity.

Authors:  Christian Bjørbaek
Journal:  J Investig Med       Date:  2009-10       Impact factor: 2.895

6.  Tea contains potent inhibitors of tyrosine phosphatase PTP1B.

Authors:  Junfeng Ma; Zhe Li; Shu Xing; Wan-Ting Tina Ho; Xueqi Fu; Zhizhuang Joe Zhao
Journal:  Biochem Biophys Res Commun       Date:  2011-02-28       Impact factor: 3.575

7.  Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age.

Authors:  Christopher D Morrison; Christy L White; Zhong Wang; Seung-Yub Lee; David S Lawrence; William T Cefalu; Zhong-Yin Zhang; Thomas W Gettys
Journal:  Endocrinology       Date:  2006-10-12       Impact factor: 4.736

Review 8.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 9.  The molecular regulation of Janus kinase (JAK) activation.

Authors:  Jeffrey J Babon; Isabelle S Lucet; James M Murphy; Nicos A Nicola; Leila N Varghese
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

10.  Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats.

Authors:  Paty Karoll Picardi; Vivian Cristine Calegari; Patricia Oliveira Prada; Patrícia de Oliveira Prada; Juliana Contin Moraes; Eliana Araújo; Maria Cristina Cintra Gomes Marcondes; Miriam Ueno; José Barreto Campello Carvalheira; Licio Augusto Velloso; Mario José Abdalla Saad
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.